Literature DB >> 4888206

[Cooperative controlled trial of thiocarlide (DATC), PAS and bedrest alone in short-term single-drug treatment in retreated cavitary pulmonary tuberculosis].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4888206

Source DB:  PubMed          Journal:  Beitr Klin Erforsch Tuberk Lungenkr        ISSN： 0300-9696


× No keyword cloud information.
  35 in total

1.  [ETHIONAMIDE IN DOUBLE OR TRIPLE COMBINATION IN CHRONIC PRETREATED CAVERNOUS PULMONARY TUBERCULOSIS].

Authors:  I SCHUETZ; K BARTMANN
Journal:  Prax Pneumol       Date:  1964-05

2.  [Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation].

Authors:  G CANETTI; N RIST; J GROSSET
Journal:  Rev Tuberc Pneumol (Paris)       Date:  1963 Feb-Mar

3.  [Comparison of 3 antitubercular therapeutic programs comprising isoniazid with 4,4'-diisoamyloxythiocarbanilide. streptomycin and calcium-benzoyl-PAS].

Authors:  G FAVEZ; P VULLIEMOZ; P BREAUD
Journal:  Acta Tuberc Pneumol Belg       Date:  1963 Jan-Feb

4.  [MICROBIOLOGICALLY DETERMINED ISONIAZID CONCENTRATIONS IN THE TISSUES OF ANIMAL AND MAN].

Authors:  K BARTMANN; G FREISE
Journal:  Beitr Klin Tuberk Spezif Tuberkuloseforsch       Date:  1963-10-18

5.  COMPARISON OF PAS, THIACETAZONE OR 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE WITH STREPTOMYCIN AND ISONIAZID IN PREVIOUSLY UNTREATED PATIENTS WITH PULMONARY TUBERCULOSIS.

Authors:  I KASS
Journal:  Tubercle       Date:  1965-06

6.  A summary of the results of East African-British Medical Research Council studies of thiacetazone-containing regimens.

Authors:  J F Heffernan
Journal:  Tubercle       Date:  1968-03

7.  [Bacteriologic blood concentration studies in the mono-medication of isoxyl (diisoamyloxythiocarbanilide)].

Authors:  C D Bloedner
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1965-05-31

8.  [On isoxyl treatment].

Authors:  H Heidelbach; G Meissner; W Ohm; H W Rauch; K H Schmelzer; P G Schmidt
Journal:  Prax Pneumol       Date:  1966-07

9.  Isoxyl.

Authors: 
Journal:  Tubercle       Date:  1965-09

10.  [Experimental research on 4,4'-diisoamyloxy-thiocarbanilide (Isoxyl)].

Authors:  M LUCCHESI
Journal:  Acta Tuberc Pneumol Belg       Date:  1963 Jan-Feb
View more
  8 in total

1.  A comparison of rifampicin, ethambutol or PAS in short-term monotherapy in pretreated cavitary pulmonary tuberculosis.

Authors: 
Journal:  Pneumonologie       Date:  1975-12-12

2.  Ethionamide+cycloserine+pas vs isoniazid+streptomycin+pas in initial antiburerculosis chemotherapy followed by the standard regimen. A controlled study with special reference to the microscopic enumeration of bacillia as a criterion of efficacy.

Authors: 
Journal:  Pneumonologie       Date:  1975

Review 3.  The pharmacokinetics of para-aminosalicylic acid and its relationship to efficacy and intolerance.

Authors:  Ahmed A Abulfathi; Peter R Donald; Kim Adams; Elin M Svensson; Andreas H Diacon; Helmuth Reuter
Journal:  Br J Clin Pharmacol       Date:  2020-06-21       Impact factor: 4.335

Review 4.  Antibiotic resistance mechanisms in M. tuberculosis: an update.

Authors:  Liem Nguyen
Journal:  Arch Toxicol       Date:  2016-05-09       Impact factor: 5.153

Review 5.  [Results of chemotherapy in tuberculosis].

Authors:  E Jancik
Journal:  Pneumonologie       Date:  1971

6.  [Avoidable mistakes in antitubercular chemotherapy].

Authors:  K L Radenbach
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1969

7.  Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis.

Authors:  Anneke C Hesseling; Paolo Denti; Louvina E van der Laan; Anthony J Garcia-Prats; H Simon Schaaf; Maxwell Chirehwa; Jana L Winckler; Jun Mao; Heather R Draper; Lubbe Wiesner; Jennifer Norman; Helen McIlleron; Peter R Donald
Journal:  Antimicrob Agents Chemother       Date:  2022-05-04       Impact factor: 5.938

Review 8.  What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis.

Authors:  H R Stagg; R J Harris; H-A Hatherell; D Obach; H Zhao; N Tsuchiya; K Kranzer; V Nikolayevskyy; J Kim; M C Lipman; I Abubakar
Journal:  Thorax       Date:  2016-06-13       Impact factor: 9.139
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.